Ixtlan Biosciences was an Israeli-based biotech company working with natural psilocybin mushrooms in the field of Alzheimer’s and dementia diseases.
Ixtlan was developing naturally derived psilocybin formulations for the treatment of neurodegenerative disorders.
Activities
Pharmaceutical
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates